Researchers identify a potential biomarker of Parkinson's disease progression

Parkinson's Research News

Researchers identify a potential biomarker of Parkinson's disease progression
Chronic IllnessDiseases And ConditionsAlzheimer's Research
  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 65 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 53%
  • Publisher: 53%

Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a significant increase in the levels of a molecule called ecto-GPR37 in the cerebrospinal fluid.

Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a significant increase in the levels of a molecule called ecto-GPR37 in the cerebrospinal fluid.

According to the researcher, patients with rapid progression have an accelerated onset and worsening of symptoms, motor fluctuations and complications, as well as an increased likelihood of cognitive impairment and psychiatric symptoms. In contrast, patients with slow progression have a gradual onset and progression of symptoms and can maintain higher levels of functional ability and for longer periods of time. In addition, they often have milder symptoms, especially in the early stages.

The results of this analysis show that ecto-GPR37 levels were only increased in patients with slowly progressive Parkinson's disease, and not in the fast type or in the other pathologies."This finding suggests a possible connection between the processing and expression of GPR37 and the speed of disease progression," says Francisco Ciruela.

Moreover, the researchers, thanks to funding from the Michael J. Fox Foundation, have recently adapted an assay to determine the presence of ecto-GPR37 in blood samples from patients,"which makes it much easier to determine analytically," they conclude.Josep Argerich, Leonardo D. Garma, Marc López-Cano, Paula Álvarez-Montoya, Laura Gómez-Acero, Víctor Fernández-Dueñas, Ana B.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceDaily /  🏆 452. in US

Chronic Illness Diseases And Conditions Alzheimer's Research Parkinson's Alzheimer's Disorders And Syndromes Caregiving

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

5 lifestyle habits that can help you live to 100, according to leading longevity researchers5 lifestyle habits that can help you live to 100, according to leading longevity researchersI’ve been reporting on longevity for nearly two years. Here are the habits that stand out as most important if you’re hoping to live to 100.
Read more »

Researchers develop Janus-like metasurface technology that acts according to the direction of lightResearchers develop Janus-like metasurface technology that acts according to the direction of lightResearchers have overcome the limitations of existing metasurface technologies and successfully designed a Janus metasurface capable of perfectly controlling asymmetric light transmission.
Read more »

At-home brain stimulation for depression is safe and effective, according to researchersAt-home brain stimulation for depression is safe and effective, according to researchersA device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study.
Read more »

Sperm Appear to Have a Nonreproductive FunctionSperm Appear to Have a Nonreproductive FunctionSperm exhibit an immune response that is common to macrophages and neutrophils, according to Brazilian researchers.
Read more »

Closing in on Parkinson's Disease proteins in extracellular vesicles in the bloodClosing in on Parkinson's Disease proteins in extracellular vesicles in the bloodBrain disorders like Parkinson's or Alzheimer's Disease start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or even stop their disease, but there is currently no way to diagnose brain disorders at those pre-symptomatic stages.
Read more »

Scientists discover key to preventing neurodegeneration in Parkinson's and related disordersScientists discover key to preventing neurodegeneration in Parkinson's and related disordersA team of researchers has uncovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson's Disease.
Read more »



Render Time: 2025-02-19 17:53:42